| Pharmaceutical Information |
| Drug Name |
Sotalol |
| Drug ID |
BADD_D02060 |
| Description |
Sotalol is a methanesulfonanilide developed in 1960.[A178579] It was the first of the class III anti arrhythmic drugs.[A178579] Sotalol was first approved as an oral tablet on 30 October 1992.[L6334] A racemic mixture of sotalol is currently formulated as a tablet, oral solution, and intravenous injection indicated for life threatening ventricular arrhythmias and maintaining normal sinus rhythm in atrial fibrillation or flutter.[Label,L6373,L6376] |
| Indications and Usage |
Sotalol is indicated to treat life threatening ventricular arrhytmias and maintain normal sinus rhythm in patients with atrial fibrillation or flutter.[Label] There are also oral solutions and intravenous injections indicated for patients requiring sotalol, but for whom a tablet would not be appropriate.[Label,L6373,L6376] |
| Marketing Status |
approved |
| ATC Code |
C07AA07 |
| DrugBank ID |
DB00489
|
| KEGG ID |
D08525
|
| MeSH ID |
D013015
|
| PubChem ID |
5253
|
| TTD Drug ID |
D04VMT
|
| NDC Product Code |
Not Available |
| UNII |
A6D97U294I
|
| Synonyms |
Sotalol | Sotalol Hydrochloride | Sotalol Monohydrochloride | MJ-1999 | MJ 1999 | MJ1999 | Darob |
|
| Chemical Information |
| Molecular Formula |
C12H20N2O3S |
| CAS Registry Number |
3930-20-9 |
| SMILES |
CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
